Use of the phosphodiesterase type 5 (PDE5) inhibitor tadalafil, commonly known by the brand name Cialis, for lower urinary tract symptoms (LUTS) has been associated with an increased risk of glaucoma and related conditions, according to a large retrospective study. Além disso, the findings, published in the British Journal of Ophthalmology, were reported by Chien-Chih Chou, MD, PhD, of Taichung Veterans General Hospital in Taiwan, and colleagues. While the study revealed statistically significant differences, no entanto, the absolute added risk was less than 0.8% over five years, and the authors stressed that the research does not establish a direct causal link.
Elevated Rates of Glaucoma and Ocular Hypertension
Sobretudo, men who used the PDE5 inhibitor tadalafil for lower urinary tract symptoms had a small but statistically significant increased risk of glaucoma and ocular hypertension, consistent with prior research.
Ademais, the current large retrospective study confirms that rates of glaucoma, ocular hypertension, and open-angle glaucoma were significantly higher in men with a history of tadalafil prescriptions for LUTS. Consequentemente, moreover, these patients were significantly more likely to initiate treatment for glaucoma than their counterparts who did not use a PDE5 inhibitor.
Em resumo, Chien-Chih Chou, MD, PhD, and his team underscored that the findings do not prove that PDE5 inhibition can cause glaucoma but rather add to the growing evidence base associating the drug class with ophthalmic conditions.
Expert Commentary Highlights Key Limitations
Perspective from Dr. Stephen Freedland
Principalmente, Stephen Freedland, MD, of Cedars-Sinai Medical Center in Los Angeles, offered an external perspective, describing the work as an “interesting hypothesis-generating analysis.” Ademais, he noted several limitations that should temper interpretation.
Além disso, speaking to MedPage Today, Freedland pointed out that tadalafil is used not only for LUTS but also for erectile dysfunction, and it remains uncertain whether the observed eye problems are a direct effect of the medication or related to the underlying conditions that prompted its use.
Em seguida, he added that the absolute risk increase—less than 0.8% over half a decade—is modest. Consequentemente, mandating routine ophthalmic examinations for all men starting tadalafil for LUTS would, in his view, place a disproportionate burden on the healthcare system given such a small absolute effect.
Portanto, these considerations remind clinicians and patients that single studies should be interpreted within the broader context of medical evidence.
Broader Ocular Concerns with PDE5 Inhibitors
Documented Severe Eye Conditions
PDE5 inhibitors have long been under scrutiny for their potential ocular side effects. Por exemplo, reports have documented rare but severe events such as retinal detachment, retinal vascular occlusion, and ischemic optic neuropathy among users of this drug class.
An earlier retrospective study had already found a small but statistically significant increased risk of glaucoma and ocular hypertension in men using tadalafil for lower urinary tract symptoms. Ademais, the new study adds further weight to these concerns, even though the absolute numbers remain low.
Portanto, patients taking tadalafil who notice any sudden vision changes should seek medical evaluation to rule out serious conditions.
Contradictory Signal for Erectile Dysfunction
A separate recent study indicated that tadalafil might offer a protective effect against ocular adverse events when used for erectile dysfunction. No entanto, this finding contrasts with the glaucoma signal seen in LUTS patients, and the source did not provide details on the reasons for this discrepancy.
Researchers are unsure whether the protective association reflects a true biological effect or confounding factors, and they stress that no clinical recommendations can be drawn from this signal alone. Consequentemente, further investigation is needed to clarify these opposing observations.
Clinical Recommendations and Patient Conversations
When to Consult a Doctor
Given the modest absolute risk increase of less than 0.8% over five years, health experts do not advocate for routine ophthalmic screening for all men on tadalafil. Contudo, however, clinicians should consider discussing the potential eye-related symptoms with their patients, especially those with a family history of glaucoma or other predisposing conditions.
Patients are advised to continue their medication as prescribed and to consult their healthcare provider if they have any concerns. Além disso, as research evolves, updated guidelines may provide more specific recommendations. Em resumo, until then, an open dialogue between patients and their doctors remains essential.
Frequently Asked Questions
How much does tadalafil for lower urinary tract symptoms increase the risk of glaucoma?
Em resumo, men taking tadalafil for LUTS had a significantly higher risk of glaucoma, with an absolute increase of less than 0.8% over 5 years, according to a retrospective study.
Does tadalafil used for erectile dysfunction have the same eye risk as for LUTS?
No, a recent study suggested a protective effect against ocular adverse events when tadalafil is prescribed for erectile dysfunction, contudo, unlike the increased glaucoma risk seen with LUTS use.
Should men on tadalafil for LUTS get regular eye exams for glaucoma?
While the study found a small increased risk, experts caution that routine ophthalmic follow-up for all such men would be a huge burden on the health system given the less than 0.8% increased risk. Ademais, additionally, the study does not prove causation.
Source
- www.medpagetoday.com
- British Journal of Ophthalmology (bjo.bmj.com)
- Inhibition of PDE5 (pubmed.ncbi.nlm.nih.gov)
- comments powered by Disqus. (disqus.com)
